9, 10 and 11 However, the effect of IL-1Ra on bone remodelling after mechanical loading is not well described. In the present study, administration of IL-1Ra diminished OTM by reducing the expression of the pro-inflammatory cytokines NVP-LDE225 clinical trial IL-1β and TNF-α, and by increasing the levels of IL-10, a negative regulator of bone resorption. When an orthodontic

force is applied on teeth, it leads to a transient aseptic inflammation of the periodontium that culminates in bone remodelling.1 In this context, bone resorption is a fundamental step and several cytokines associated to osteoclast differentiation and activation, such as TNF-α and IL-1β, are early released in the periodontium after mechanical loading.3, 4, 18, 19 and 20 Accordingly, the levels of these cytokines were increased in our experimental conditions, whilst the levels of IL-10, a cytokine known to control bone resorption and osteoclast activation,21 were not affected. In view of the importance of this inflammatory milieu to bone resorption, it has been suggested that the control of such inflammation could affect OTM. A previous study showed that an interference with TNF-α activity might decrease

osteoclast migration and, consequently, Rucaparib chemical structure diminish OTM.18 In this regard, administration of IL-1Ra to interfere with IL-1β activity could also alter mechanically induced bone remodelling. IL-1Ra, first called IL-1 inhibitor, was cloned and identified as an IL-1 receptor antagonist after being noticed to bind to IL-1 receptors but not to transduce the same signals that IL-1β did.22 and 23 Thus, IL-1Ra acts by competitively blocking the interactions of IL-1 to their receptors, inhibiting its activities.7 and 8 Indeed, the administration of exogenous

IL-1 receptor antagonist has been shown to be effective in reducing signs of IL-1-related bone resorptive conditions, such as rheumatoid arthritis10 and periodontal disease,11 concomitantly with a reduction of pro-inflammatory cytokines.9 and 11 In this regard, a decreased physiological IL-1Ra expression in gingival crevicular fluid has been shown to correlate with faster OTM in humans.14, 15, 16 and 17 Sirolimus datasheet In the present study, mice treated with IL-1Ra showed significantly diminished OTM and osteoclast numbers than vehicle-treated animals. This phenotype was associated with reduced early release of TNF-α and IL-1β, concomitantly to increased expression of IL-10 on periodontal tissues. The present results give support to previous findings showing that administration of soluble IL-1 receptors reduces the amount of OTM in rats24 and go further when showing that this effect occurs by controlling the expression of cytokines.